0R2M.L | Regeneron Pharmaceuticals, Inc. Annual &

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	33.08 Billion	29.21 Billion	25.43 Billion	17.16 Billion	14.8 Billion	11.73 Billion
Total Current Assets	19.47 Billion	22.06 Billion	20.52 Billion	12.75 Billion	10.55 Billion	7.95 Billion
Cash And Short Term Investments	10.84 Billion	14.33 Billion	12.53 Billion	6.72 Billion	6.47 Billion	4.56 Billion
Cash and Cash Equivalents	2.73 Billion	3.1 Billion	2.88 Billion	2.19 Billion	1.61 Billion	1.46 Billion
Short Term Investments	8.11 Billion	4.63 Billion	2.8 Billion	1.39 Billion	1.59 Billion	1.34 Billion
Net Receivables	5.66 Billion	5.32 Billion	6.03 Billion	4.11 Billion	2.67 Billion	2.24 Billion
Inventory	2.58 Billion	2.4 Billion	1.95 Billion	1.91 Billion	1.41 Billion	1.15 Billion
Other Current Assets	386.6 Million	933 Million	332.4 Million	1.16 Billion	959.3 Million	243.3 Million
Total Non-Current Assets	13.6 Billion	7.14 Billion	4.91 Billion	4.4 Billion	4.24 Billion	3.77 Billion
Net PPE	4.14 Billion	3.76 Billion	3.48 Billion	3.22 Billion	2.89 Billion	2.57 Billion
Good Will And Intangible Assets	1.03 Billion	915.5 Million	-6.83 Billion	-3.13 Billion	-3.25 Billion	-1.75 Billion
Good Will	-	-	-6.84 Billion	-	-	-
Intangible Assets	1.03 Billion	915.5 Million	6.7 Million	-	-	-
Long-Term Investments	5.39 Billion	5.4 Billion	6.83 Billion	3.13 Billion	3.25 Billion	1.75 Billion
Tax Assets	2.57 Billion	1.72 Billion	876.9 Million	858.9 Million	824.2 Million	828.7 Million
Other Non Current Assets	444.1 Million	-4.65 Billion	555.2 Million	328.9 Million	531.8 Million	370.7 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	7.1 Billion	6.55 Billion	6.66 Billion	6.13 Billion	3.71 Billion	2.97 Billion
Total Current Liabilities	3.42 Billion	3.84 Billion	3.45 Billion	2.8 Billion	1.79 Billion	1.35 Billion
Account Payables	606.6 Million	589.2 Million	564 Million	475.5 Million	418.1 Million	218.2 Million
Tax Payables	-	300 Thousand	326.3 Million	19.5 Million	49.4 Million	20.8 Million
Short Term Debt	-	720 Million	719.7 Million	1.63 Billion	-	-90.8 Million
Deferred Revenue	458.9 Million	547.7 Million	442 Million	577.7 Million	591.7 Million	452.5 Million
Other Current Liabilities	2.35 Billion	1.99 Billion	1.72 Billion	122.4 Million	781.1 Million	772.1 Million
Total Non Current Liabilities	3.68 Billion	2.7 Billion	3.21 Billion	3.33 Billion	1.92 Billion	1.62 Billion
Long-Term Debt	2.7 Billion	2.7 Billion	2.69 Billion	2.69 Billion	713.9 Million	708.5 Million
Deferred Revenue Non Current	126.7 Million	69.8 Million	515.3 Million	635.5 Million	1.21 Billion	916.7 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	803.7 Million	-128 Million	680.2 Million	687.1 Million	286 Million	502 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	25.97 Billion	22.66 Billion	18.76 Billion	11.02 Billion	11.08 Billion	8.75 Billion
Stock Holders Equity	25.97 Billion	22.66 Billion	18.76 Billion	11.02 Billion	11.08 Billion	8.75 Billion
Common Stock	100 Thousand	100 Thousand	100 Thousand	100 Thousand	100 Thousand	100 Thousand
Retained Earnings	27.26 Billion	23.3 Billion	18.96 Billion	10.89 Billion	7.37 Billion	5.25 Billion
Accumulated other comprehensive income	-80.9 Million	-238.8 Million	-26.2 Million	29.3 Million	21.1 Million	-12.3 Million
Common Stock Equity	25.97 Billion	22.66 Billion	18.76 Billion	11.02 Billion	11.08 Billion	8.75 Billion
Capital Lease Obligation	720 Million	720 Million	719.7 Million	717.2 Million	713.9 Million	708.5 Million
Total Investments	13.51 Billion	10.04 Billion	9.64 Billion	4.52 Billion	4.85 Billion	3.09 Billion
Total Debt	2.7 Billion	2.7 Billion	2.69 Billion	2.69 Billion	713.9 Million	708.5 Million
Net Debt	-27.1 Million	-404.5 Million	-185.9 Million	502 Million	-903.9 Million	-759.2 Million

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3
Total Assets	37.44 Billion	36.08 Billion	34.36 Billion	33.08 Billion	33.08 Billion	32.16 Billion
Total Current Assets	19.33 Billion	19.08 Billion	18.87 Billion	19.47 Billion	19.47 Billion	18.63 Billion
Cash And Short Term Investments	9.79 Billion	9.81 Billion	10.51 Billion	10.84 Billion	10.84 Billion	9.91 Billion
Cash and Cash Equivalents	2.01 Billion	1.92 Billion	2.6 Billion	2.73 Billion	2.73 Billion	2.15 Billion
Short Term Investments	7.78 Billion	7.88 Billion	7.91 Billion	8.11 Billion	8.11 Billion	7.76 Billion
Net Receivables	6.1 Billion	5.71 Billion	5.22 Billion	5.66 Billion	5.66 Billion	5.58 Billion
Inventory	3.01 Billion	2.87 Billion	2.71 Billion	2.58 Billion	2.58 Billion	2.56 Billion
Other Current Assets	412 Million	674.4 Million	414.9 Million	386.6 Million	386.6 Million	574.7 Million
Total Non-Current Assets	18.1 Billion	17 Billion	15.49 Billion	13.6 Billion	13.6 Billion	13.52 Billion
Net PPE	4.43 Billion	4.3 Billion	4.22 Billion	4.14 Billion	4.14 Billion	4 Billion
Good Will And Intangible Assets	1.12 Billion	1.1 Billion	1.05 Billion	1.03 Billion	1.03 Billion	1.01 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	1.12 Billion	1.1 Billion	1.05 Billion	1.03 Billion	1.03 Billion	1.01 Billion
Long-Term Investments	8.65 Billion	7.91 Billion	7.06 Billion	5.39 Billion	5.39 Billion	5.77 Billion
Tax Assets	3.01 Billion	2.88 Billion	2.76 Billion	2.57 Billion	2.57 Billion	2.31 Billion
Other Non Current Assets	883.2 Million	797 Million	388.69 Million	444.1 Million	444.1 Million	409.9 Million
Other Assets	-	-	1.00	-	-	-
Total Liabilities	8.11 Billion	7.88 Billion	7.37 Billion	7.1 Billion	7.1 Billion	7.25 Billion
Total Current Liabilities	3.66 Billion	3.5 Billion	3.58 Billion	3.42 Billion	3.42 Billion	3.59 Billion
Account Payables	497.3 Million	561.7 Million	671.3 Million	606.6 Million	606.6 Million	536.6 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	-	-	1.00	-	-	-
Deferred Revenue	627.2 Million	586 Million	516.7 Million	458.9 Million	458.9 Million	417.3 Million
Other Current Liabilities	2.53 Billion	2.36 Billion	2.39 Billion	2.35 Billion	2.35 Billion	2.64 Billion
Total Non Current Liabilities	4.45 Billion	4.37 Billion	3.79 Billion	3.68 Billion	3.68 Billion	3.66 Billion
Long-Term Debt	2.7 Billion	1.98 Billion	1.98 Billion	2.7 Billion	2.7 Billion	2.7 Billion
Deferred Revenue Non Current	207.4 Million	205.6 Million	185.8 Million	126.7 Million	126.7 Million	125.3 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.75 Billion	1.46 Billion	908.5 Million	803.7 Million	803.7 Million	832.4 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	29.32 Billion	28.2 Billion	26.99 Billion	25.97 Billion	25.97 Billion	24.9 Billion
Stock Holders Equity	29.32 Billion	28.2 Billion	26.99 Billion	25.97 Billion	25.97 Billion	24.9 Billion
Common Stock	100 Thousand	100 Thousand	100 Thousand	100 Thousand	100 Thousand	100 Thousand
Retained Earnings	30.75 Billion	29.41 Billion	27.98 Billion	27.26 Billion	27.26 Billion	26.1 Billion
Accumulated other comprehensive income	60.2 Million	-69.9 Million	-77.2 Million	-80.9 Million	-80.9 Million	-176.8 Million
Common Stock Equity	29.32 Billion	28.2 Billion	26.99 Billion	25.97 Billion	25.97 Billion	24.9 Billion
Capital Lease Obligation	720 Million	720 Million	720 Million	720 Million	720 Million	720 Million
Total Investments	7.78 Billion	15.8 Billion	14.97 Billion	13.51 Billion	16.24 Billion	7.76 Billion
Total Debt	2.7 Billion	2.7 Billion	2.7 Billion	2.7 Billion	2.7 Billion	2.7 Billion
Net Debt	692.2 Million	775.4 Million	101.3 Million	-27.1 Million	-27.1 Million	550.3 Million

Balance Sheet Charts

VIQ Solutions Inc.

VQSSF

Full Analysis

Annual Balance Sheets
Johnson Outdoors Inc.

JOUT

Full Analysis

Annual Balance Sheets
McCoy Global Inc.

MCB

Full Analysis

Annual Balance Sheets
Krung Thai Bank Public Company Limited

KTB-R

Full Analysis

Annual Balance Sheets
Fulton Financial Corporation

FULTP

Full Analysis

Annual Balance Sheets
Public Service Enterprise Group Incorporated

PEG

Full Analysis

Annual Balance Sheets

Global Stocks Search

Regeneron Pharmaceuticals, Inc. (0R2M.L)

Annual Balance Sheets

Balance Sheet Charts

VIQ Solutions Inc.

Johnson Outdoors Inc.

McCoy Global Inc.

Krung Thai Bank Public Company Limited

Fulton Financial Corporation

Public Service Enterprise Group Incorporated